​​How Does Olopatadine Safeguard Allergy Patients?

Olopatadine is an H1 receptor antagonist primarily used to treat allergic rhinitis, urticaria, eczema, and related conditions. The olopatadine hydrochloride tablet (Trade Name: Allelock®) was first developed by Kyowa Kirin Co., Ltd. and approved in Japan in 2000.

Allergic diseases such as eczema and urticaria often manifest with sudden, intense itching—described as "invisible needles." For instance, urticaria involves widespread wheals and pruritus, with severe cases potentially accompanied by angioedema. The most distressing symptom is persistent, severe itching, triggered by diverse factors including seafood, medications, physical stimuli, and emotional stress. Most patients experience recurrent episodes.

Currently, there is no cure for urticaria; symptom control relies on standardized pharmacotherapy. Second-generation antihistamines (e.g., olopatadine, loratadine) are first-line treatments. Olopatadine‘s core advantage lies in its selective H1 receptor antagonism, which inhibits the release of histamine and generation of allergic mediators (e.g., leukotrienes, thromboxane, PAF). Clinical studies demonstrate significant efficacy in reducing wheals and pruritus for acute/chronic urticaria, with favorable safety profiles. After 3 months of continuous use, >80% of patients achieve symptomatic relief; approximately 50% remain recurrence-free at 6 months without dependency .

(Treatment should be tailored to symptom type, comorbidities, and individual factors under medical guidance.)

Impurity control is critical for drug efficacy and safety. Olopatadine may generate impurities during synthesis, storage, or metabolism. The Chinese Pharmacopoeia (2025 Edition) mandates limits of ≤0.1% for any single impurity and ≤0.25% for total impurities . High-purity impurity reference standards serve as both technical pillars for drug development and compliance tools throughout the product lifecycle.

SZEB supplies a comprehensive range of olopatadine impurities, including:​​Stereoisomers: (E)-Olopatadine (CAS: 113806-06-7)，​​Aldehyde Impurities​​，​​Halogenated Impurities​​，​​Epoxide Derivatives​​，​​Dealkylated Impurities etc  

More impurity information at the website:www.ex-biotech.com

Contact us by e-mail:sales@ex-biotech.com